CBP-HSF2 structural and functional interplay in Rubinstein-Taybi neurodevelopmental disorder
| dc.contributor.author | de Thonel Aurélie | |
| dc.contributor.author | Ahlskog Johanna K. | |
| dc.contributor.author | Daupin Kevin | |
| dc.contributor.author | Dubreuil Véronique | |
| dc.contributor.author | Berthelet Jérémy | |
| dc.contributor.author | Chaput Carole | |
| dc.contributor.author | Pires Geoffrey | |
| dc.contributor.author | Leonetti Camille | |
| dc.contributor.author | Abane Ryma | |
| dc.contributor.author | Barris Lluís Cordón | |
| dc.contributor.author | Leray Isabelle | |
| dc.contributor.author | Aalto Anna L. | |
| dc.contributor.author | Naceri Sarah | |
| dc.contributor.author | Cordonnier Marine | |
| dc.contributor.author | Benasolo Carène | |
| dc.contributor.author | Sanial Matthieu | |
| dc.contributor.author | Duchateau Agathe | |
| dc.contributor.author | Vihervaara Anniina | |
| dc.contributor.author | Puustinen Mikael C. | |
| dc.contributor.author | Miozzo Federico | |
| dc.contributor.author | Fergelot Patricia | |
| dc.contributor.author | Lebigot Élise | |
| dc.contributor.author | Verloes Alain | |
| dc.contributor.author | Gressens Pierre | |
| dc.contributor.author | Lacombe Didier | |
| dc.contributor.author | Gobbo Jessica | |
| dc.contributor.author | Garrido Carmen | |
| dc.contributor.author | Westerheide Sandy D. | |
| dc.contributor.author | David Laurent | |
| dc.contributor.author | Petitjean Michel | |
| dc.contributor.author | Taboureau Olivier | |
| dc.contributor.author | Rodrigues-Lima Fernando | |
| dc.contributor.author | Passemard Sandrine | |
| dc.contributor.author | Sabéran-Djoneidi Délara | |
| dc.contributor.author | Nguyen Laurent | |
| dc.contributor.author | Lancaster Madeline | |
| dc.contributor.author | Sistonen Lea | |
| dc.contributor.author | Mezger Valérie | |
| dc.contributor.organization | fi=Turun biotiedekeskus|en=Turku Bioscience Centre| | |
| dc.contributor.organization-code | 1.2.246.10.2458963.20.18586209670 | |
| dc.contributor.organization-code | 2609200 | |
| dc.converis.publication-id | 177597977 | |
| dc.converis.url | https://research.utu.fi/converis/portal/Publication/177597977 | |
| dc.date.accessioned | 2023-01-07T03:30:11Z | |
| dc.date.available | 2023-01-07T03:30:11Z | |
| dc.description.abstract | <p>Rubinstein-Taybi syndrome (RSTS) is a neurodevelopmental disorder with unclear underlying mechanisms. Here, the authors unravel the contribution of a stress-responsive pathway to RSTS where impaired HSF2 acetylation, due to RSTS-associated CBP/EP300 mutations, alters the expression of neurodevelopmental players, in keeping with hallmarks of cell-cell adhesion defects.Patients carrying autosomal dominant mutations in the histone/lysine acetyl transferases CBP or EP300 develop a neurodevelopmental disorder: Rubinstein-Taybi syndrome (RSTS). The biological pathways underlying these neurodevelopmental defects remain elusive. Here, we unravel the contribution of a stress-responsive pathway to RSTS. We characterize the structural and functional interaction between CBP/EP300 and heat-shock factor 2 (HSF2), a tuner of brain cortical development and major player in prenatal stress responses in the neocortex: CBP/EP300 acetylates HSF2, leading to the stabilization of the HSF2 protein. Consequently, RSTS patient-derived primary cells show decreased levels of HSF2 and HSF2-dependent alteration in their repertoire of molecular chaperones and stress response. Moreover, we unravel a CBP/EP300-HSF2-N-cadherin cascade that is also active in neurodevelopmental contexts, and show that its deregulation disturbs neuroepithelial integrity in 2D and 3D organoid models of cerebral development, generated from RSTS patient-derived iPSC cells, providing a molecular reading key for this complex pathology.<br></p> | |
| dc.identifier.eissn | 2041-1723 | |
| dc.identifier.jour-issn | 2041-1723 | |
| dc.identifier.olddbid | 190964 | |
| dc.identifier.oldhandle | 10024/174054 | |
| dc.identifier.uri | https://www.utupub.fi/handle/11111/32238 | |
| dc.identifier.url | https://www.nature.com/articles/s41467-022-34476-2 | |
| dc.identifier.urn | URN:NBN:fi-fe202301051536 | |
| dc.language.iso | en | |
| dc.okm.affiliatedauthor | Vihervaara, Anniina | |
| dc.okm.affiliatedauthor | Puustinen, Mikael | |
| dc.okm.affiliatedauthor | Sistonen, Lea | |
| dc.okm.discipline | 3111 Biomedicine | en_GB |
| dc.okm.discipline | 3111 Biolääketieteet | fi_FI |
| dc.okm.internationalcopublication | international co-publication | |
| dc.okm.internationality | International publication | |
| dc.okm.type | A1 ScientificArticle | |
| dc.publisher | NATURE PORTFOLIO | |
| dc.publisher.country | United Kingdom | en_GB |
| dc.publisher.country | Britannia | fi_FI |
| dc.publisher.country-code | GB | |
| dc.relation.articlenumber | 7002 | |
| dc.relation.doi | 10.1038/s41467-022-34476-2 | |
| dc.relation.ispartofjournal | Nature Communications | |
| dc.relation.issue | 1 | |
| dc.relation.volume | 13 | |
| dc.source.identifier | https://www.utupub.fi/handle/10024/174054 | |
| dc.title | CBP-HSF2 structural and functional interplay in Rubinstein-Taybi neurodevelopmental disorder | |
| dc.year.issued | 2022 |
Tiedostot
1 - 1 / 1